Connect with us

Rohypnol (flunitrazepam)

Flunitrazepam (or ROHYPNOL®) is mainly prescribed to treat severe insomnia.

Status: ACTIVE

Class: Benzodiazepine

FDA Approval: (International: AU, UK)

Dosage Forms: 0.5 mg, 1 mg, 2 mg

Biological Half-life: 18-26 hours

Side Effects: Dizziness, sleepiness, blurred vision, anterograde amnesia, slurred speech, confusion, nausea, gastrointestinal disturbances

Precautions: May significantly impair driving or motor skills; used as date rape drug

Routes of Administration: Oral

Pregnancy Category: C (AU)


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.